KVUE 24.09 Stock Price Kenvue Inc.
Range: | 17.67-24.125 | Vol Avg: | 15263762 | Last Div: | 0.82 | Changes: | 0.21 |
Beta: | 1.26 | Cap: | 45.67B | Currency: | USD | Exchange: | NYSE |
Sector: | Consumer Defensive | IPO: | Thu May 04 2023 | Empoloyees: | 22000 |
CUSIP: | 49177J102 | CIK: | 0001944048 | ISIN: | US49177J1025 | Country: | US |
CEO: | Mr. Thibaut Mongon | Website: | https://www.kenvue.com |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.